Astec Lifesciences

Astec life -update(past performance and future growth triggers)

ASTEC

1…PERFORMANCE

-20-30% cagr growth upto 2022
-Negative de growth in 2023 and 2024

=Topline and profitability were severely impacted due to
-sluggish demand,
-lower realizations and
-high-cost inventories of enterprise products

=CDMO business grew 3.0x y-o-y led by new product development while profitability also improved

2…Future growth triggers

A…CDMO business

=Increasing Cdmo business
=Management guided huge expansion for CDMO business in 2025(Howeve
r it is still not finally decided)

B…Herbicide plant
=Completed in 2022-2023
=Diversification into herbicides and development of more triazole molecules in enterprise business.

C…RnD

=Completion of R and D centre
= R&D Center will catalyze Godrej Group’s ambition to be an application-agnostic partner of choice for innovator companies in the rapidly growing chemical industry in Cdmo business.

D…Enterprisisng business
=Recovery from enterprising business

Disc…invested

2 Likes